COMPOSITION

Product: Ps-CBD (softgels)
Label claims on pack: “CBD 1500 mg” and “60 Pcs Softgels” (PS LABS / ps-co.net).
Per-unit estimate: 1500 mg ÷ 60 ≈ 25 mg CBD per softgel (inferred from the pack total; confirm on the official label/CoA).
THC / excipients: Not stated on the box; verify %THC and carrier oil on the Certificate of Analysis.

Real-life Example:
A carton contains one or more blisters/bottles totaling 60 softgels. A typical daily serving could be 1 softgel (≈25 mg CBD), adjusted per clinician guidance.

DESCRIPTION

Cannabidiol (CBD) is a non-intoxicating phytocannabinoid from Cannabis sativa. Ps-CBD provides CBD in softgel form for convenient, consistent dosing. CBD does not cause the “high” associated with THC. A purified prescription CBD exists for certain epilepsies; evidence for many other uses is still evolving, and over-the-counter products often carry unproven claims.

Real-life Example:
Someone wanting a measured dose without taste selects Ps-CBD softgels instead of oils/tinctures.

SIDE EFFECTS

Possible effects (dose-dependent):

• Drowsiness/fatigue

• Dry mouth, decreased appetite, or diarrhea

• Dizziness

• Liver enzyme elevations at higher doses or with interacting drugs

Real-life Example:
A user taking 25–50 mg/day notices daytime sleepiness and reduces to 25 mg/day, with liver enzymes checked if using regularly.

PREGNANCY

Not recommended during pregnancy or breastfeeding due to insufficient safety data and potential risks to fetal/infant development.

Real-life Example:
A pregnant person considering CBD for nausea is advised to avoid it and use evidence-based options discussed with a clinician.

DRUG INTERACTIONS

CBD can inhibit CYP3A4 and CYP2C19, potentially increasing levels of:

• Clobazam/benzodiazepines → excess sedation

• Valproate → higher risk of liver enzyme elevations

• Warfarin/anticoagulants → altered INR/bleeding risk

• Other CYP-metabolized drugs (some antidepressants, antipsychotics, anticonvulsants)

Real-life Example:
A patient on warfarin starts Ps-CBD; their clinician increases INR monitoring and adjusts dosing as needed.

INDICATION

Established (prescription-grade CBD only):

• Seizures in Lennox–Gastaut, Dravet, Tuberous Sclerosis Complex.

Common OTC uses (evidence mixed/insufficient):

• Anxiety, pain, sleep disturbance, general well-being.

Real-life Example:
An adult with situational anxiety tries one 25 mg softgel in the evening, tracks response, and consults their clinician—especially if taking other meds.

STORAGE INSTRUCTIONS

Store in a cool, dry place, away from heat and direct sunlight. Keep tightly closed in original packaging. Follow any pack instructions (e.g., “refrigerate after opening,” if stated). Keep out of reach of children.

Real-life Example:
The carton is kept in a room-temperature cabinet; the user avoids leaving the softgels in a hot car, which could degrade the product.

Notes & assumptions based on the photo:

• Branding shows Ps-CBD / PS LABS, “CBD 1500 mg”, and “60 Pcs Softgels.”

• Per-softgel strength (≈25 mg) is calculated from the front-panel total; confirm exact per-unit amount, THC content, and carrier oil via the detailed label or Certificate of Analysis (CoA).

• Regulations and legal THC limits vary by region; verify local compliance.

• This document is informational and not a substitute for medical advice.